TABLE 1.

Demographics of the patients

	Drug treated	Control
n	21	21
Sex (male/female)	14/7	12/9
Age (years)	13.9 ± 1.17	14.9 ± 1.31
History of DKA	20	21
HbA1c at entry (%)	8.98 ± 0.38*	7.97 ± 0.24
Fasting C-peptide	0.207 ± 0.026	0.210 ± 0.015
GAD (%)	81	74
ICA512 (%)	71	74
IAA (%)	62	74

Data are means ± SE unless noted otherwise from the time of study entry.

^*P < 0.05.